The PDUFA Act needs to be reauthorized, and the risk of FDA layoffs has not been eliminated
ADC评论
September 24, 2022
Recently, a senior Republican committee aide revealed to the media Endpoints News that although policy negotiations including additional provisions (accelerated approval of reforms, etc.) are
